Dolby Laboratories opened higher at $64.78, compared with its previous close of $64.66. In the last trading session, the stock traded between $64.24 and $65.01. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Dolby Laboratories is now worth
$ 73.02
Resulting in a loss of
$ 26.98 (26.98%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.06 (-0.10%)
Day High
$65.01
Day Low
$64.24
Day Open
$64.78
Prev Close
$64.66
Volume
3,74,715
1W Return
-0.67%
1M Return
11.28%
3M Return
5.27%
6M Return
12.17%
1Y Return
-1.78%
Fundamentals
Market Cap ($ Mn)
3,838
PE Ratio
26.17
PB Ratio
2.23
PEG Ratio
8.46
ROE
10.03%
ROCE
10.46%
EPS (TTM)
$0.31
Investment Returns
1 Week
-0.67%
1 Month
11.28%
3 Months
5.27%
6 Months
12.17%
9 Months
-6.50%
Financials
Quarterly
All values in $ Mn
369.6
Mar 25
315.5
Jun 25
307.0
Sep 25
346.7
Dec 25
395.6
Mar 26
305.0
Jun 26
Updates
24Sep
Dolby and Meta expand Atmos, Vision across AI glasses and Instagram
Dolby and Meta expand Atmos and Vision across AI glasses, Instagram, and VR. Meta AI glasses become first global consumer device with Dolby Atmos capture. New VR device will support Dolby Vision and Atmos upon launch next year.
Dolby Laboratories forecasts Q4 sales of $362M-$392M, exceeding estimates. GAAP EPS is guided at $0.78-$0.93 vs $0.79 estimate, with adjusted EPS at $1.13-$1.28 vs $1.20.
Dolby Laboratories has revised its FY26 financial outlook downward, cutting adjusted EPS guidance to $4.25-$4.40 from $4.30-$4.45 and narrowing sales guidance to $1.41B-$1.44B from $1.40B-$1.45B. Both metrics now fall at or below analyst estimates, signaling caution.
Dolby Laboratories delivered mixed third-quarter results, with adjusted EPS of $0.69 beating the $0.67 estimate by 2.99 percent. However, sales of $304.995 million missed the $311.960 million forecast by 2.23 percent. Both metrics showed year-over-year declines, with EPS down 11.54 percent and sales down 3.34 percent from the prior year period.
3mo ago
15Jul
Dolby Laboratories schedules Q3 FY26 results for July 30
Dolby Laboratories will release Q3 FY26 financial results on July 30, 2026, followed by a management-led conference call at 2:00 p.m. PT. Investors can access the event via webcast or registration. The webcast will be archived for one year.
